Unclear Grammar Lands AbbVie-Novartis IP Row In Arbitration
A California federal judge on Thursday sent AbbVie Inc.'s suit seeking to nix Novartis' hepatitis C patents to arbitration, finding that while a licensing agreement between the companies was so grammatically...To view the full article, register now.
Already a subscriber? Click here to view full article